Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Pulmonary Hypertension

  Free Subscription


07.01.2019

1 Am J Physiol Lung Cell Mol Physiol
1 Antioxid Redox Signal
1 Biomed Pharmacother
1 Clin Physiol Funct Imaging
3 Eur Heart J Cardiovasc Imaging
3 Eur Respir J
1 Exp Lung Res
1 Heart Lung Circ
1 Int J Cardiol Heart Vasc
1 Int J Mol Sci
1 Intern Emerg Med
1 Iran J Kidney Dis
1 Life Sci
1 Lung India


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Physiol Lung Cell Mol Physiol

  1. RAFIKOV R, McBride ML, Zemskova M, Kurdyukov S, et al
    INOSITOL MONOPHOSPHATASE 1 (IMPA1) AS A NOVEL INTERACTING PARTNER OF RAGE IN PULMONARY HYPERTENSION.
    Am J Physiol Lung Cell Mol Physiol. 2019 Jan 3. doi: 10.1152/ajplung.00393.2018.
    PubMed     Text format     Abstract available


    Antioxid Redox Signal

  2. SULIMAN HB, Nozik-Grayck E
    Mitochondrial Dysfunction: Metabolic Drivers of Pulmonary Hypertension.
    Antioxid Redox Signal. 2019 Jan 3. doi: 10.1089/ars.2018.7705.
    PubMed     Text format     Abstract available


    Biomed Pharmacother

  3. HUA C, Zhao J, Wang H, Chen F, et al
    Apple polyphenol relieves hypoxia-induced pulmonary arterial hypertension via pulmonary endothelium protection and smooth muscle relaxation: In vivo and in vitro studies.
    Biomed Pharmacother. 2018;107:937-944.
    PubMed     Text format     Abstract available


    Clin Physiol Funct Imaging

  4. LINDHOLM A, Hesselstrand R, Radegran G, Arheden H, et al
    Decreased biventricular longitudinal strain in patients with systemic sclerosis is mainly caused by pulmonary hypertension and not by systemic sclerosis per se.
    Clin Physiol Funct Imaging. 2018 Dec 31. doi: 10.1111/cpf.12561.
    PubMed     Text format     Abstract available


    Eur Heart J Cardiovasc Imaging

  5. REHMAN MB, Howard LS, Christiaens LP, Gill D, et al
    Resting right ventricular function is associated with exercise performance in PAH, but not in CTEPH.
    Eur Heart J Cardiovasc Imaging. 2018;19:185-192.
    PubMed     Text format     Abstract available

  6. PLOEGSTRA MJ, Brokelman JGM, Roos-Hesselink JW, Douwes JM, et al
    Pulmonary arterial stiffness indices assessed by intravascular ultrasound in children with early pulmonary vascular disease: prediction of advanced disease and mortality during 20-year follow-up.
    Eur Heart J Cardiovasc Imaging. 2018;19:216-224.
    PubMed     Text format     Abstract available

  7. KANAOKA K, Horii M, Nagato H, Kaneda K, et al
    A giant pulmonary artery aneurysm.
    Eur Heart J Cardiovasc Imaging. 2018;19:236.
    PubMed     Text format    


    Eur Respir J

  8. BOUCLY A, Weatherald J, Humbert M, Sitbon O, et al
    Risk assessment in pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    PubMed     Text format    

  9. HOEPER MM, Pittrow D, Opitz C, Gibbs JSR, et al
    Risk assessment in pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    PubMed     Text format    

  10. DACCORD C, Letovanec I, Yerly P, Bloch J, et al
    First histopathological evidence of irreversible pulmonary vascular disease in dasatinib-induced pulmonary arterial hypertension.
    Eur Respir J. 2018;51.
    PubMed     Text format    


    Exp Lung Res

  11. LACHANT DJ, Meoli DF, Haight D, Lyons JA, et al
    Low dose monocrotaline causes a selective pulmonary vascular lesion in male and female pneumonectomized rats.
    Exp Lung Res. 2018;44:51-61.
    PubMed     Text format     Abstract available


    Heart Lung Circ

  12. MAGON W, Stepniewski J, Miszalski-Jamka T, Urbanczyk-Zawadzka M, et al
    Right Ventricular Epicardial Vascularisation in Patients With Pulmonary Arterial Hypertension.
    Heart Lung Circ. 2018;27:1428-1436.
    PubMed     Text format     Abstract available


    Int J Cardiol Heart Vasc

  13. CHEN C, Liu J, Liu Z, He X, et al
    Electrocardiogram signs of right ventricular hypertrophy may help identify pulmonary hypertension in patients with dilated cardiomyopathy.
    Int J Cardiol Heart Vasc. 2018;22:61-66.
    PubMed     Text format     Abstract available


    Int J Mol Sci

  14. POTUS F, Hindmarch CCT, Dunham-Snary KJ, Stafford J, et al
    Transcriptomic Signature of Right Ventricular Failure in Experimental Pulmonary Arterial Hypertension: Deep Sequencing Demonstrates Mitochondrial, Fibrotic, Inflammatory and Angiogenic Abnormalities.
    Int J Mol Sci. 2018;19.
    PubMed     Text format     Abstract available


    Intern Emerg Med

  15. CHENG CY, Zhang YX, Denas G, Du Y, et al
    Prevalence of antiphospholipid (aPL) antibodies among patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis.
    Intern Emerg Med. 2019 Jan 2. pii: 10.1007/s11739-018-02021.
    PubMed     Text format     Abstract available


    Iran J Kidney Dis

  16. MIRI M, Hejazi S, Maghsoudlou F, Ahmadi M, et al
    Prevalence of Pulmonary Hypertension in End-stage Renal Disease Patients Undergoing Hemodialysis and Peritoneal Dialysis at a Referral Center in Mashhad, Iran, From 2015 to 2016.
    Iran J Kidney Dis. 2018;12:364-368.
    PubMed     Text format     Abstract available


    Life Sci

  17. ZHANG YT, Xue JJ, Wang Q, Cheng SY, et al
    Dehydroepiandrosterone attenuates pulmonary artery and right ventricular remodeling in a rat model of pulmonary hypertension due to left heart failure.
    Life Sci. 2018 Dec 31. pii: S0024-3205(18)30857.
    PubMed     Text format     Abstract available


    Lung India

  18. SENGUPTA S, Dey D, Bhattacharyya P
    Correlating between chronic obstructive pulmonary disease assessment test and emPHasis score in Group III pulmonary hypertension patients.
    Lung India. 2019;36:86-87.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: